Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Miriam Potrony
Based on 15 articles published since 2009
(Why 15 articles?)
||||
Expertise Level
The expertise of Miriam Potrony ranks in the
  • Top 1.7%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 15 articles on the topic.
Graphical view (beta)
Aliases Potrony, Miriam   ·   Potrony, M
Work Locations
Details
Most likely:    Instituto de Salud Carlos III      
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
2016
  • Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. , · Melanoma Unit, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain. · Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Private Dermatology Practice, Lugano, Switzerland. · Private Dermatology Practice, Bellinzona, Switzerland. · Private Dermatology Practice, Chiasso, Switzerland. · Private Dermatology Practice, Locarno, Switzerland. · Istituto Oncologico della Svizzera Italiana (IOSI), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Biochemistry and Molecular Genetics Service, Hospital Clinic of Barcelona, Spain. · Pubmed 27473757
2014
  • Department of Dermatology,University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen and the German Cancer Consortium (KGG, BS, EL, TS, IM, MS, AS, UH, LZ, DS), Germany · Department of Pathology and Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY (RM) · CIBER Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain (JAPB, MP, CC, CB, JM, SP) · Department of Dermatology, Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain (CC, JM, SP) · Biochemistry and Molecular Genetics Department, Hospital Clinic Barcelona, IDIBAPS, Barcelona, Spain (CB) · Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena, Germany (AS). · Pubmed 25217772
  • Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Electronic address: · Pubmed 25064638
2015
  • Dermatology, Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS); Center for Biomedical Network Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII). · Pubmed 25631192
Probable:    Universitat de Barcelona      
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
  • Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Dermatology Department, Hospital Alemán, Buenos Aires, Argentina. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Medicine Department, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28950052
2017
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Barcelona, Spain. · Pubmed 28103633
  • Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK. · Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Clınic de Barcelona, Barcelona, Spain. · Melanoma Unit, Radiology Service, Hospital Clınic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, Barcelona, Spain. · Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Melanoma Unit, Radiotherapy Oncology, Hospital Clınic, IDIBAPS, Barcelona University, Barcelona, Spain. · Leiden University Medical Centre, Leiden, The Netherlands. · Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico. · Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 28097802
2016
  • Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain2Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil3Pontifícia Universidade Católica do Rio Grande do Sul, School of Medicine, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain4Centro de Investigación Biomédica en Red en Enfermedades Raras, Barcelona, Spain. · Pubmed 27579522
  • Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. , · Melanoma Unit, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain. · Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Private Dermatology Practice, Lugano, Switzerland. · Private Dermatology Practice, Bellinzona, Switzerland. · Private Dermatology Practice, Chiasso, Switzerland. · Private Dermatology Practice, Locarno, Switzerland. · Istituto Oncologico della Svizzera Italiana (IOSI), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Biochemistry and Molecular Genetics Service, Hospital Clinic of Barcelona, Spain. · Pubmed 27473757
  • Melanoma Unit, Dermatology Department, Hospital Clínic De Barcelona, IDIBAPS, Universitat De Barcelona, Barcelona, Spain. · Grup D'Immunoreceptors Del Sistema Innat I Adaptatiu, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic De Barcelona, Barcelona, Spain. · Centro De Investigación Biomédica En Red En Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology, Hospital Clínic De Barcelona, Barcelona, Spain. · Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona, Spain. · Pubmed 27169428
  • Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Departament de Medicina, Universitat de Barcelona, Barcelona, Spain. · Consejo Nacional de Ciencia y Tecnología (CONACYT), Ciudad de México, México. · Melanoma Unit, Biochemistry and Molecular Genetics Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Universidad Católica de Valencia, Valencia, Spain. · Molecular Biology Unit, Instituto Valenciano de Oncologia, Valencia, Spain. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany. · Escola Paulista de Medicina - UNIFESP, São Paulo, Brazil. · International Research Center, AC Camargo Cancer Center, São Paulo, Brazil. · Dermatology Department and Post-Graduation Program of Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil. · Servicio de Dermatología, Hospital Dr. Sótero del Río, Santiago de Chile, Chile. · Servicio de Dermatología, Hospital San Juan de Dios, Santiago, Chile. · Pontificia Universidad Católica de Chile, Santiago de Chile, Chile. · Department of Dermatology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Instituto de Investigaciones Medicas "A Lanari," Universidad de Buenos Aires, Buenos Aires, Argentina. · Consultorio Dermatológico Drs. Cohen Sabban y Cabo, Buenos Aires, Argentina. · Hospital Especialidades Centro Medico Nacional La Raza, Mexico, DF, Mexico. · Departamento de Ciencias Básicas, Escuela de Medicina Universidad de Monterrey, Monterrey, Mexico. · Departamento de Introducción a la Clínica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Servicio de Dermatología, Hospital Universitario "Dr. José Eleuterio González," Monterrey, Mexico. · Pubmed 26681309
  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain3Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic de Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain. · Department of Dermatology, Hospital Universitari Son Espases, Palma Mallorca, Spain. · Servicio de Dermatología del Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Pubmed 26650189
2015
  • Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Medicine Department, University of Barcelona (UB), Barcelona, Spain. · Pubmed 25913870
2014
  • Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Electronic address: · Pubmed 25064638
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 15 total) written by Miriam Potrony about Melanoma:

  • Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11q. 2018
  • Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi. 2018
  • IRF4 rs12203592 functional variant and melanoma survival. 2017
  • Genomic analysis and clinical management of adolescent cutaneous melanoma. 2017
  • Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas. 2016
  • Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF. 2016
  • Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival. 2016
  • Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas. 2016
  • Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma. 2016
  • Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations. 2016
Show List of Full Article Records
Google Searches

Learn more about Miriam Potrony using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Instituto de Salud Carlos III
Universitat de Barcelona
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Instituto de Salud Carlos III
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
2016
  • Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. , · Melanoma Unit, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain. · Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Private Dermatology Practice, Lugano, Switzerland. · Private Dermatology Practice, Bellinzona, Switzerland. · Private Dermatology Practice, Chiasso, Switzerland. · Private Dermatology Practice, Locarno, Switzerland. · Istituto Oncologico della Svizzera Italiana (IOSI), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Biochemistry and Molecular Genetics Service, Hospital Clinic of Barcelona, Spain. · Pubmed 27473757
2014
  • Department of Dermatology,University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen and the German Cancer Consortium (KGG, BS, EL, TS, IM, MS, AS, UH, LZ, DS), Germany · Department of Pathology and Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY (RM) · CIBER Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain (JAPB, MP, CC, CB, JM, SP) · Department of Dermatology, Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain (CC, JM, SP) · Biochemistry and Molecular Genetics Department, Hospital Clinic Barcelona, IDIBAPS, Barcelona, Spain (CB) · Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena, Germany (AS). · Pubmed 25217772
  • Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Electronic address: · Pubmed 25064638
2015
  • Dermatology, Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS); Center for Biomedical Network Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII). · Pubmed 25631192
Universitat de Barcelona
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
  • Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Dermatology Department, Hospital Alemán, Buenos Aires, Argentina. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Medicine Department, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28950052
2017
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Barcelona, Spain. · Pubmed 28103633
  • Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK. · Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Clınic de Barcelona, Barcelona, Spain. · Melanoma Unit, Radiology Service, Hospital Clınic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, Barcelona, Spain. · Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Melanoma Unit, Radiotherapy Oncology, Hospital Clınic, IDIBAPS, Barcelona University, Barcelona, Spain. · Leiden University Medical Centre, Leiden, The Netherlands. · Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico. · Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 28097802
2016
  • Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain2Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil3Pontifícia Universidade Católica do Rio Grande do Sul, School of Medicine, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain4Centro de Investigación Biomédica en Red en Enfermedades Raras, Barcelona, Spain. · Pubmed 27579522
  • Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. , · Melanoma Unit, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain. · Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Private Dermatology Practice, Lugano, Switzerland. · Private Dermatology Practice, Bellinzona, Switzerland. · Private Dermatology Practice, Chiasso, Switzerland. · Private Dermatology Practice, Locarno, Switzerland. · Istituto Oncologico della Svizzera Italiana (IOSI), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Biochemistry and Molecular Genetics Service, Hospital Clinic of Barcelona, Spain. · Pubmed 27473757
  • Melanoma Unit, Dermatology Department, Hospital Clínic De Barcelona, IDIBAPS, Universitat De Barcelona, Barcelona, Spain. · Grup D'Immunoreceptors Del Sistema Innat I Adaptatiu, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic De Barcelona, Barcelona, Spain. · Centro De Investigación Biomédica En Red En Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology, Hospital Clínic De Barcelona, Barcelona, Spain. · Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona, Spain. · Pubmed 27169428
  • Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Departament de Medicina, Universitat de Barcelona, Barcelona, Spain. · Consejo Nacional de Ciencia y Tecnología (CONACYT), Ciudad de México, México. · Melanoma Unit, Biochemistry and Molecular Genetics Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Universidad Católica de Valencia, Valencia, Spain. · Molecular Biology Unit, Instituto Valenciano de Oncologia, Valencia, Spain. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany. · Escola Paulista de Medicina - UNIFESP, São Paulo, Brazil. · International Research Center, AC Camargo Cancer Center, São Paulo, Brazil. · Dermatology Department and Post-Graduation Program of Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil. · Servicio de Dermatología, Hospital Dr. Sótero del Río, Santiago de Chile, Chile. · Servicio de Dermatología, Hospital San Juan de Dios, Santiago, Chile. · Pontificia Universidad Católica de Chile, Santiago de Chile, Chile. · Department of Dermatology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Instituto de Investigaciones Medicas "A Lanari," Universidad de Buenos Aires, Buenos Aires, Argentina. · Consultorio Dermatológico Drs. Cohen Sabban y Cabo, Buenos Aires, Argentina. · Hospital Especialidades Centro Medico Nacional La Raza, Mexico, DF, Mexico. · Departamento de Ciencias Básicas, Escuela de Medicina Universidad de Monterrey, Monterrey, Mexico. · Departamento de Introducción a la Clínica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Servicio de Dermatología, Hospital Universitario "Dr. José Eleuterio González," Monterrey, Mexico. · Pubmed 26681309
  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain3Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic de Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain. · Department of Dermatology, Hospital Universitari Son Espases, Palma Mallorca, Spain. · Servicio de Dermatología del Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Pubmed 26650189
2015
  • Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Medicine Department, University of Barcelona (UB), Barcelona, Spain. · Pubmed 25913870
2014
  • Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Electronic address: · Pubmed 25064638
Unspecified
2016
  • Dermatology Department, Melanoma Unit, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Center for Networked Biomedical Research on Rare Diseases, Carlos III Health Institute. · Biochemical and Molecular Genetics Service, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases. · Medicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 26389780
Yearly article counts 02272200000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.